The BactiVac network was launched on 14 August 2017 following the award of £2.2 million funding under the Medical Research Council’s (MRC) GCRF Networks in Vaccines Research and Development initiative. The network is hosted in Birmingham within the Institute of Immunology and Immunotherapy and is led by Professor Calman MacLennan (Honorary Professor of Vaccine Immunology) and Professor Adam Cunningham (Professor of Functional Immunity).
The BactiVac network will support the establishment of a global bacterial vaccinology network to accelerate the development of vaccines against bacterial infections relevant to low and middle-income countries (LMICs). It is the first network of its kind to focus specifically on bacterial infections.
It will achieve its aims through promoting cross-collaboration between academic and industrial partners in developed and developing nations involved in vaccine research against human and animal bacterial infections.
As well as fostering new partnerships through advocacy and joint meetings, it will fund catalyst projects and training to accelerate vaccine development, particularly at the preclinical to clinical transitional bottleneck, the point of failure for so many vaccines.